Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Microneedle Stamp for Peanut Allergy Moves Through First Human Trial

Company Developing Novel Food Allergy Treatment Raises $3.5 Million in Seed...

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Study: The Effect of OIT in Severe Milk, Peanut and Egg...

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Study: Nine Children Suffer Severe Symptoms in OIT Trial

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Eczema Drug Makes Significant Progress as EoE Treatment

Follow Us

Your School On Our Map

Put Your School on the Map